HeartBeam granted new patent for VECG platform from USPTO

HeartBeam announced that the United States Patent and Trademark Office, or USPTO, has granted a new patent on HeartBeam’s novel VECG platform. The latest patent, “Electrocardiogram Patch Devices and Methods” describes methods and systems for remote detection and/or diagnosis of acute myocardial infarction through handheld and adhesive devices. This is HeartBeam’s third issued US patent on its novel on-demand 12-lead wearable cardiac monitor, strengthening the company’s position in the large global electrocardiogram patch market which is estimated to reach $4.8B by 2030.